Abstract
Purpose: To compare the efficacy and safety of rimexolone 1% and prednisolone acetate 1% ophthalmic suspensions in controlling intraocular inflammation in the early period after cataract surgery. Methods: Eighty patients undergoing cataract extraction with intraocular lens implantation, either planned extra capsular cataract extraction (PECCE) or phacoemulsification surgery, were evaluated in a prospective, randomized, observer-masked, clinical trial in which efficacy in controlling early postoperative inflammation and safety of prednisolone acetate 1% one eye drop every 4 h (n = 36 eyes) was compared with that of rimexolone 1% one eye drop every 4 h (n = 44 eyes) in an eighteen day course. Efficacy was assessed from changes of the anterior chamber cell count, flare, conjunctival hyperemia, and ciliary congestion by means of slit lamp biomicroscopy on days 1, 3, 8, 15, and 18. Intraocular pressure (IOP) and possible side effects were also recorded on each visit. Results: Anterior chamber cell count and flare showed no difference in the two groups at any visits. The rimexolone group was associated with significantly higher score for conjunctival hyperemia on days one and three (P < 0.05) and the prednisolone acetate group was associated with a significantly higher score for corneal edema on day 8 (P < 0,05). However, there were no between group differences in IOP. Conclusions: Rimexolone 1% ophthalmic suspension was as effective and safe as prednisolone acetate 1% ophthalmic suspension in controlling inflammation in the early period after cataract surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leibowitz HM, Kupferman A (1975) Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 79:78–88
Simone JN, Whitecare MM (2001) Effects of anti-inflammatory drugs following cataract extraction. Curr Opinion Ophthalmol 12:63–67
Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Steward R, Assil K (1996) Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 116:933–937
Rowen S (1999) Preoperative and postoperative medications used for cataract surgery. Curr Opin Ophthalmol 10:29–35
Assil KK, Massry G, Lehnmann R, Fox K, Stewart R (1997) Control of ocular inflammation after cataract extraction with rimexolone 1% ophthalmic suspension. J Cataract Refract Surg 23:750–757
Bron A, Hoang Xuan TC, Boureaux Andrieux C, Crozafon B, Hachet E, Medhorn E et al (1996) The effects of rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. Eur J Ophthalmol 8:16–21
Foster S, Alter G, DeBarge R, Raizman M, Crabb J, Santos C et al (1996) Efficacy and safety of rimexolone 1% ophthalmic suspension vs prednisolone acetate 1% in the treatment of uveitis. Am J Ophthalmol 122:171–182
Stark WJ, Whithney CE, Chandler JW, Worthern DM (1986) Trends in intraocular lens implantation in the United States. Arch Ophthalmol 104:1769–1770
Lehnmann R, Assil K, Stewart R, Fox K (1995) Comparison of rimexolone 1% ophthalmic suspension to placebo in control of postcataract surgery inflammation. Invest Ophthalmol Vis Sci 36(Suppl):793
Armaly MF (1963) Effects of corticosteroids on intraocular pressure and fluid dynamics 1. The effects of the dexametasone in the normal eye. Arch Ophthalmol 70:482–491
Ronen S, Rozenman Y, Zylbermann R, Berson D (1985) Treatment of ocular inflammation with diclofenac sodium: double blind trial following cataract surgery. Ann Ophthalmol 17:577–581
Becker B (1965) Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci 4:198–205
Fan DPS, Yu OBG, Chiu TYH, Wong YC, Ng JSK et al (2003) Ocular hypertensive and anti-inflammatory response to rimexolone therapy in children. Arch Ophthalmol 121:1716–1721
Carnahan MC, Goldstein DA (2000) Ocular complications of topical, periocular and systemic corticosteroids. Curr Opinion Ophthal 11:478–483
Hirneiss C, Neubauer AS, Kampik A, Schonfeld CL (2005) Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. Graefes Arch Clin Exp Ophthalmol 243(8):768–773
Biswas J, Ganeshbabu TM, Raghevenderan SR, Raizada S, Mondkar SV, Madhavan HN (2004) Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis a randomized triple masked study. Int Ophthalmol 25(3):147–153
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kavuncu, S., Horoz, H., Ardagil, A. et al. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. Int Ophthalmol 28, 281–285 (2008). https://doi.org/10.1007/s10792-007-9131-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9131-0